Recombinant SARS-CoV-2 Nucleocapsid antibody (DBCO)

Catalog No. ABIN7272897

The Alpaca Monoclonal anti-SARS-CoV-2 Nucleocapsid antibody has been validated for IF and ICC. It is suitable to detect SARS-CoV-2 Nucleocapsid in samples from SARS Coronavirus-2 (SARS-CoV-2).

Quick Overview for Recombinant SARS-CoV-2 Nucleocapsid antibody (DBCO) (ABIN7272897)

Target: SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)

Antibody Type: Recombinant Antibody

Fragment: single-domain Antibody (sdAb)

Reactivity: SARS Coronavirus-2 (SARS-CoV-2)

Host: Alpaca

Clonality: Monoclonal

Conjugate: This SARS-CoV-2 Nucleocapsid antibody is conjugated to DBCO

Application: Immunofluorescence (IF), Immunocytochemistry (ICC)

Clone: 2A7

Product Details anti-SARS-CoV-2 Nucleocapsid Antibody (DBCO)

Expression System: E.coli

Specificity: Nucleocapsid from SARS-CoV-2 and SARS-CoV-1

Purification: Produced in: E.coli

Immunogen: Our nanobody binds strongly to protein N of SARS-CoV-2, even under harsh sample treatment conditions, e.g. paraffin-embedded tissue.

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Reconsitute with 250 µL 50% glycerol for storage at -80 °C

Buffer: sdAbs are lyophilized from PBS pH 7.4.

Storage: 4 °C/-20 °C

Storage Comment: Vials containing lyophilized protein can be stored at 4°C for up to 6 months. Vials containing reconstituted protein should be stored at -20°C or below.

Target Details for SARS-CoV-2 Nucleocapsid

Target: SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)

Alternative Name: Nucleocapsid from SARS-CoV-2

Background: The nucleocapsid (N) protein of SARS-CoV-2 is an abundant RNA-binding protein critical for the packaging of the single-stranded RNA viral genome. Due to its abundance, it is an interesting target for antibody detection in biopsies and tissue. The protein N is also present inside virion particles bound to single-stranded RNA.